CDEK
← All drugs Report issue

indeglitazar

Small moleculeexperimental

Plexxikon is an American drug discovery company based in South San Francisco, California. It was co-founded in 2001 by Joseph Schlessinger of Yale University, and Sung-Hou Kim of the University of California, Berkeley. — Wikipedia

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2006 (NCT00448032)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COc1ccc(S(=O)(=O)n2cc(CCC(=O)O)c3cc(OC)ccc32)cc1
Mol. weight
389.43 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • indeglitazar
  • indeglitazar
  • indeglitazar
  • ppm-204
  • ppm-204
  • ppm-204

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00425919Phase 2Jan 1, 2007Pfizer, Wyeth
NCT00447629Phase 1Jan 1, 2007Pfizer, Wyeth
NCT00448032Phase 1Nov 1, 2006Pfizer, Wyeth
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
PfizerFor profit3322006
WyethFor profit3022006
2 organizations
Page 1 / 1